News

Valneva announced excellent final Phase 1 results for its single-shot chikungunya vaccine candidate, VLA1553.

Valneva announced the appointment of two leading vaccine experts to its Scientific Advisory Board (SAB). Dr. Norman W. Baylor, PhD, and Dr. George R....

13 Nov'19

The European Commission has officially established Euro-BioImaging – which provides life scientists with open access to a broad range of technologies...

08 Nov'19

In the frame of the Vienna BioCenter PhD Student Symposium "Re-Connect", five former students of the international PhD Programme received awards for...

06 Nov'19

The Wellcome Trust Innovator Award of ~£500K complements the previously secured ~€11 million funding from public sources for the vaccine’s development...

05 Nov'19

On December 2nd, IMBA scientific director Jürgen Knoblich, is part of the Vienna Lectures, promoting an interdisciplinary and public debate about...

31 Oct'19

Valneva reported its nine-month financial results ending September 30, 2019.

29 Oct'19

Shotaro Otsuka did his PhD at Kyoto University in Japan with a major in biophysics. For his postdoctoral research he moved to the European Molecular...

28 Oct'19

Blinded evaluation study with leading global IVD player demonstrated diagnostic performance in line with FDA requirements for antibiotic...

25 Oct'19

An international team of scientists have discovered a novel biochemical process that is based on an alternative energy carrier. This discovery...

25 Oct'19

a:head bio AG today announced a long-term partnership with the Institute of Molecular Biotechnology (IMBA) in Vienna, Austria for the development of...

24 Oct'19

Johanna Gassler, PhD student in the lab of Kikue Tachibana at IMBA, receives the prestigious l`Oréal Women in Science fellowship.

Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans

Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board

Euro-BioImaging officially established with Austria as one of the founding members

Vienna BioCenter PhD Awards 2019

Eveliqure's effort to develop a Shigella-ETEC combination vaccine for travelers and children in resource poor countries is supported by the Wellcome Trust

Limits vs. chances of Biotechnology: A public debate

Valneva Raises Product Sales Guidance Following Strong Nine-Month Results and R&D Execution

Seeing is Believing – Understanding inter-organelle communication with cutting edge microscopy

Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test

Essential biochemical process driven by alternative cellular fuel discovered

a:head signs license and collaboration agreements with IMBA and awarded funding from FFG

FOR WOMEN IN SCIENCE - IMBA PhD student receives L'Oréal fellowship